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Due to advanced disease at the time of diagnosis the prognosis of oesophageal cancer is generally poor. As mass screening for
oesophageal cancer is neither feasible nor reasonable, high-risk groups should be identiﬁed and surveilled. The aim of this
study was to deﬁne the risk of oesophageal cancer in patients with (previous) head and neck cancer. A total of 148 patients
with (previous) head and neck cancer were prospectively screened for oesophageal cancer by video-oesophagoscopy and
random oesophageal biopsies. Even in a macroscopically normal looking oesophagus, four biopsy specimens were taken every
3 cm throughout the entire length of the squamous oesophagus. Low- or high-grade squamous cell dysplasia was detected
histologically in 10 of the 148 patients (6.8%). All but one dysplasias were diagnosed synchronously with the head and neck
cancers. In addition, oesophageal squamous cell carcinoma was diagnosed in 11 of the 148 patients (7.4%). Most invasive
cancers (63.6%) occurred metachronously. The risk of squamous cell neoplasia of the oesophagus is high in patients with
(previous) head and neck cancer. Surveillance is recommended in this high-risk group.
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Heavy consumption of alcohol and tobacco is responsible for
synchronous and metachronous primary malignancies in the upper
aerodigestive tract. When a second oesophageal malignancy devel-
ops in a patient with previous head and neck cancer (HNC), the
prognosis is determined by the oesophageal cancer, and unfortu-
nately it is poor (Cooper et al, 1989; Leon et al, 1999). This is
due to the advanced tumour stage at which oesophageal cancer
becomes symptomatic. In patients with both HNC and oesophageal
cancer, the former often develops ﬁrst, and there are more meta-
chronous than synchronous cases (Cooper et al, 1989; Makuuchi
et al, 1996; Agrawal and Wenig, 1998; Leon et al, 1999). Screening
for oesophageal squamous cell cancer has therefore been advocated
for HNC patients (Cooper et al, 1989; Makuuchi et al, 1996;
Horiuchi et al, 1998).
In analogy to the well-studied colorectal carcinogenesis,
Mandard et al (2000) recently suggested a model of genetic
steps in the development of squamous cell cancer of the oeso-
phagus. The sequence of histopathological changes includes
esophagitis, atrophy, mild to severe dysplasia, carcinoma in situ
and, ﬁnally, invasive oesophageal cancer. The concept of a step-
wise carcinogenesis implies the efﬁcacy of surveillance in
patients at high risk for squamous cell cancer of the oesopha-
gus. Patients who survived HNC are known to develop a
second neoplasm with a risk of 3–7% per year (Cooper et
al, 1989; Sturgis and Miller, 1995). Prospective studies in Japan
and recently in Brazil detected oesophageal squamous cell
neoplasia in 5.1–11.8% of HNC patients (Shiozaki et al,
1990; Makuuchi et al, 1996; Tincani et al, 2000). General
surveillance of HNC patients is not yet recommended in
Western countries, mainly due to a lack of adequate data from
this part of the world (Agrawal and Wenig, 1998; Deleyiannis
and Weymuller, 1998).
In this study we used high-resolution video-oesophagoscopy to
prospectively screen 148 HNC patients for oesophageal squamous
neoplasia. To detect early histological changes even in a macrosco-
pically normal looking oesophagus, we took multiple biopsies
according to a systematic endoscopic biopsy protocol. The high
rate of oesophageal neoplasia we observed conﬁrms previous data
from Japan and argues for a more general surveillance of HNC
patients. As chromoendoscopy with Lugol staining only moder-
ately improves the diagnostic accuracy of video-endoscopy
(Meyer et al, 1997) in oesophageal squamous cell neoplasia, we
applied Lugol chromoendoscopy only to assess the mucosal exten-
sion of early neoplastic lesions and to search for any additional
neoplastic foci.
MATERIALS AND METHODS
Patients
A prospective study involving 148 patients with HNC was carried
out at the University Hospital Benjamin Franklin in Berlin from
May 2000 to August 2001. An oesophagogastroduodenoscopy with
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www.bjcancer.comsystematic oesophageal biopsies was suggested to all patients who
presented with a previous history or ﬁrst diagnosis of head and
neck cancer (oral cavity, larynx, oro- or hypopharynx) to either
the ENT Department, the Department of Maxillofacial Plastic
Surgery or the Department of Gastroenterology. Patients with oeso-
phageal varices or bleeding disorders were excluded. The study was
approved by the Ethics Committee of the University Hospital
Benjamin Franklin, Free University Berlin.
The 148 patients ranged in age from 34 to 89 years (average 61.0
years). Forty-two patients were women. The primary head and
neck cancer was located in either the oral cavity (n=59), orophar-
ynx (n=48), hypopharynx (n=23) or larynx (n=18 patients). In
cases with multiple metachronous primary malignancies, the ﬁrst
head and neck carcinoma was regarded as the index tumour. When
multiple head and neck tumours were diagnosed simultaneously,
the tumour that caused the presenting complaint was chosen as
the index lesion.
The oesophageal neoplasm was classiﬁed as synchronous if diag-
nosed within 6 months after the diagnosis of HNC and
metachronous if diagnosed after a period of 6 months. Seventy-ﬁve
of the 148 HNC patients were oesophagoscoped within 6 months
after the diagnosis of HNC.
Endoscopy
All endoscopies were performed using a high-resolution video-
endoscopes (GIF-XQ 140, Olympus Optical Co. (Europa) GmbH,
Hamburg, Germany). Biopsy specimens were obtained with the
7.5 mm open span biopsy forceps (K02 22 V-A, Endo-Flex,
Voerde, Germany). Biopsy specimens were taken every 3 cm
throughout the entire length of the squamous oesophagus, starting
3 cm above the gastrooesophageal junction. Four biopsies were
taken from each level and placed in different bottles so that the
locations could be separately documented. Even in a macroscopi-
cally normal looking oesophagus, 20 to 28 biopsies were sampled
according to this systematic endoscopic biopsy protocol. In addi-
tion, multiple specimens were taken of any endoscopic
abnormality.
Histology
The ﬁnal diagnosis was based on an independent review of the
cases by two to three observers. If dysplasia was found, the micro-
sections were evaluated by three different pathologists. All
observers agreed on the diagnosis of cancer or dysplasia in the
patients described in this study. In specimens where there was
no complete agreement concerning the grade of dysplasia, two
out of three was considered a consensus.
Oesophageal carcinomas if restricted to the submucosal layer
were classiﬁed superﬁcial and as intraepithelial if restricted to
the epithelial layer (Endo et al, 1986; Sugimachi et al, 1988;
Mori et al, 1993; Schlemper et al, 2000c). Low- and high-grade
dysplasia (synonym: intraepithelial neoplasias; Gabbert et al,
2000) was deﬁned as unequivocal neoplastic transformation
according to criteria published previously (Lewin and Appelman,
1995).
RESULTS
Oesophageal squamous cell cancer (ESCC)
Among the 148 patients examined, 14 invasive oesophageal squa-
mous cell cancers were detected in 11 patients (7.4%; Table 1).
Three of the 11 patients even had two oesophageal cancers each;
in addition to two oesophageal cancers two of the three patients
suffered from oesophageal dysplasia at a separate third location.
In four of the 11 patients, HNC and oesophageal cancer were
diagnosed synchronously. Interestingly, the patients related their
clinical symptoms only to the head and neck region. The other
seven patients had metachronous oesophageal cancers that devel-
oped 10, 13, 27, 29, 41, 74 and 114 months after the (ﬁrst)
head and neck cancer. These patients did not present with
dysphagia. The oesophageal cancers were preceded by 15 primary
head and neck cancers (mean of 1.4 HNC per ESCC-patient). In
contrast, the HNC patients in whom no oesophageal dysplasia or
cancer was detected had suffered from a mean of 1.1 HNC per
patient.
Apart from the 148 study patients, seven further HNC patients
presenting with dysphagia during the study period were diagnosed
as suffering from squamous cell cancer of the oesophagus. Since
these seven patients complained of dysphagia, they were not
included in the group of 148 study patients. All seven patients
suffered from stenotic stage III squamous cell cancer of the oeso-
phagus. The intervals between the diagnosis of (the ﬁrst) HNC
and oesophageal cancer were 2, 3, 5, 7, 8, 9 and 13 years. The seven
patients had developed 10 HNC prior to the now presented oeso-
phageal cancers.
Oesophageal squamous cell dysplasia (ESCD)
Even in a macroscopically normal looking oesophagus we sampled
multiple biopsies according to the outlined systematic endoscopic
biopsy protocol. Oesophageal squamous cell dysplasia (eight low-
and four high-grade dysplasias) was detected in 10 of the 148
(6.8%) patients biopsied according to that protocol (Table 2). In
nine of the 10 patients, HNC and squamous cell dysplasia (=
intra-epithelial neoplasia) of the oesophagus were diagnosed
synchronously. Altogether 13 head and neck cancers had occurred
in the 10 patients with oesophageal dysplasia (mean 1.3 HNC per
patient). All patients found to suffer from dysplasias or early oeso-
phageal cancer were further examined by chromoendoscopy with
Lugol dye solution (Shiozaki et al, 1990; Endo et al, 1986; Sugima-
chi et al, 1988) and by endoscopic ultrasound (Ziegler et al, 1991).
Lugol chromoendoscopy identiﬁed all but one dysplastic lesions
and proved very helpful in assessing the mucosal extension of early
neoplastic lesions (Figure 1); additional neoplastic foci were not
detected by Lugol staining. There were no major complications
related to the endoscopic examinations or the biopsies taken.
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Table 1 Characteristics of 11 HNC patients with oesophageal squamous
cell cancer
Age 49–69 years (median 61.0 years)
Sex 3 females/8 males
Location of oesophageal cancer (n=14)
upper oesophagus 3
middle oesophagus 8
lower oesophagus 3
Stage of oesophageal cancer (n=14)
UICC stage I 6
UICC stage II 2
UICC stage III 6
Location of head and neck cancer
oral cavity 3
oropharynx 5
hypopharynx 2
larynx 1
Chronology of HNC and oesophageal cancers
a,b
synchronous 4 patients
metachronous 7 patients
time interval 10–114 months
(median 29 months)
HNC: head and neck cancer.
aSynchronous: oesophageal cancer was diagnosed with-
in 6 months after the diagnosis of HNC.
bMetachronous: oesophageal cancer was
diagnosed 6 months after the diagnosis of HNC.
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Oesophageal cancer is a disease with a dramatically different
geographic incidence. In high-risk areas like Linxian, China, mass
surveillance programmes for the malignancy have been implemen-
ted to reduce the high mortality rate of 161 per 100000 (Wu et al,
1982). In most Western countries, the incidence of oesophageal
squamous cell cancer is less than 6 per 100000 (Fleischer and
Haddad, 1999; Gabbert et al, 2000). The rarity of this neoplasm
does not justify implementing a costly endoscopic surveillance
programme for the general population in low-risk areas. However,
even in low-risk areas, surveillance may be warranted for high-risk
groups. High-risk groups for oesophageal squamous cell cancer
include male heavy drinkers and smokers, patients with corrosive
esophagitis, achalasia or with (previous) head and neck cancer
(Makuuchi et al, 1996).
The incidence of a second neoplasm in patients who survive
HNC is 3–7% per year (Cooper et al, 1989; Sturgis and Miller,
1995; Ina et al, 1994). Nevertheless, surveillance of HNC patients
has thus far not been generally recommended. This is mainly
due to a lack of adequate data, the difﬁculty of early diagnosis
and the lack of safe and effective therapeutic options (Agrawal
and Wenig, 1998; Deleyiannis and Weymuller, 1998). Here we
provide evidence that 11 patients out of a group of 148 patients
with (previous) HNC suffered from oesophageal squamous cell
cancer. This high frequency may have been biased by the referral
practice to our hospital which provides care for HNC patients in
a population of about 750000 people in the southwestern part of
Berlin. In referral centers in Germany, as many as 25–35% of
the newly diagnosed oesophageal squamous cell cancers of the
oesophagus are now reported in HNC patients. Many patients with
previous HNC may be used to some degree of odyno- or dysphagia
so that they are hardly alert to any symptoms of early oesophageal
cancer. This may explain why oesophageal cancer is generally diag-
nosed late even in patients who have already experienced the
sequelae of HNC (Cooper et al, 1989; Leon et al, 1999). Thus, in
our study, six of the 11 patients with oesophageal cancer already
had a stage III tumour disease.
In order to detect early lesions even in a macroscopically normal
looking and staining oesophagus (Fagundes et al, 1999), we took
multiple biopsies according to a systematic endoscopic biopsy
protocol and found that 6.8% (10 out of 148) of the patients biop-
sied had oesophageal squamous cell dysplasias (synonym:
intraepithelial neoplasias; Gabbert et al, 2000; Schlemper et al,
2000a–c). This high percentage compares well or even surmounts
the rates observed in previous studies (Makuuchi et al, 1996; Meyer
et al, 1997; Fagundes et al, 1999; Tincani et al, 2000; Petit et al,
2001) and provides strong evidence for the efﬁcacy of the screening
protocol used in this study. Various alternative screening strategies
have been described. These include brush-capsule cytology (Leoni-
Parvex et al, 2000), biannual oesophageal endoscopy without Lugol
staining (Petit et al, 2001), Lugol chromoendoscopy with
(Fagundes et al, 1999) or without random biopsies (Shiozaki et
al, 1990; Makuuchi et al, 1996), (auto)ﬂuorescence endoscopy
(Haringsma et al, 2001) or tri-modal spectroscopy (Georgakoudi
et al, 2001). These different strategies have, however, not yet been
compared in controlled clinical trials.
Due to its low price and general availability Lugol staining has
probably been used most commonly. Drawbacks of Lugol staining
are the low yield of neoplasia in small unstained areas (51% ESCC
risk in unstained areas of 55 mm) and the missing of normal
staining intra-epithelial neoplasias. By taking two random biopsies
in the middle of the oesophagus, Fagundes et al (1999) observed
intra-epithelial neoplasias in 7 out of 165 (4.2%) alcoholic smokers
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Figure 1 Oesophageal squamous cell cancer in a HNC patient. Left panel: Videoendoscopic image of a T1No squamous cell cancer at 25 cm from the
incisors. Twenty-nine months ago the patient had been treated for a squamous cell cancer of the oral cavity. Right panel: The same tumour after staining with
Lugol dye solution to delineate the tumour margins.
Table 2 Characteristics of 10 HNC patients with oesophageal squamous
cell dysplasia
a
Age 48–89 years (median 56.5 years)
Sex 1 female/9 males
Location of dysplasia (n=12)
upper oesophagus 6
middle oesophagus 2
lower oesophagus 4
Location of head and neck cancer
oral cavity 3
oropharynx 3
hypopharynx 3
larynx 1
Chronology of HNC and oesophageal dysplasia
b
synchronous 9 patients
metachronous 1 patient
time interval 15 months
HNC: head and neck cancer.
aSynchronous: oesophageal dysplasia was diagnosed
within 6 months after the diagnosis of HNC.
bMetachronous: oesophageal dysplasia
was diagnosed 6 months after the diagnosis of HNC.
Oesophageal squamous cell cancer
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fore, randomized controlled studies are indicated to compare the
efﬁcacy and cost effectiveness of the various strategies.
Since mucosal surfaces in the upper aerodigestive tract, lungs,
and the oesophagus are exposed to the same carcinogens, multiple
anatomical sites in the oesophagus may be at risk for the simulta-
neous or sequential development of dysplastic and malignant
lesions. This multifocal large-ﬁeld carcinogenesis is reﬂected by
the ﬁnding that 11 patients with oesophageal cancer had suffered
from a mean of 1.4 primary HNC, 10 patients with oesophageal
dysplasia from a mean of 1.3 HNC and the remaining patients
from a mean of 1.1 primary HNC. This suggests that patients with
multiple HNC have an even higher risk of developing or already
harbouring oesophageal dysplasia or cancer. Oesophageal cancer
was multifocal in 27.3% of our patients. In addition, we observed
a similar rate of oesophageal dysplasia and oesophageal squamous
cell cancer (6.8 vs 7.4%). All but one oesophageal squamous cell
dysplasias were detected synchronously, but cancer was mostly
(63.6%) diagnosed metachronously.
Thus, our ﬁndings imply that squamous cell dysplasia precedes
oesophageal squamous cell cancer. This supports the concept of a
stepwise development of oesophageal squamous cell cancer recently
put forward by Mandard et al (2000). Although most second oeso-
phageal squamous cell cancers appear to develop as independent
neoplasms, it has recently been reported that a clonal population
of neoplastic cells from the oro- or hypopharynx may be capable
of travelling substantial distances to give rise to second tumours
in the oesophagus (Califano et al, 1999).
The introduction of endoscopic oesophageal mucosal resection
(EEMR) has revolutionized the treatment of intra-epithelial oesopha-
geal neoplasia and early cancer (Makuuchi, 1996; Ell et al, 2000). In
experienced hands, this therapeutic endoscopic technique has a very
low morbidity and mortality and is an attractive alternative to oeso-
phageal resection in certain situations (Makuuchi et al, 1996;
Horiuchi et al, 1998; Ell et al, 2000). The more general availability
of EEMR offers HNC patients not only an earlier diagnosis of oeso-
phageal cancer but also an effective minimal invasive treatment
option if oesophageal squamous cell neoplasia is diagnosed early.
Photodynamic therapy (with haematoporphyrins) has also been
reported to eradicate early squamous cell cancer in HNC patients
(Savary et al, 1998). Thus, surveillance of oesophageal squamous cell
cancer is recommended in HNC patients (Makuuchi et al, 1996). In
addition, the survival beneﬁt achieved by screening for early oesopha-
geal cancer (Horiuchi et al, 1998) underlines the need for a more
general implementation of surveillance in HNC patients.
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